1 |
Zhao J, Chen Y, Xiong T, Han S, Li C, He Y, He Y, Zhao G, Wang T, Wang L, Cheng T, Wang C, Wang J. Clustered Cobalt Nanodots Initiate Ferroptosis by Upregulating Heme Oxygenase 1 for Radiotherapy Sensitization. Small 2023;19:e2206415. [PMID: 36627264 DOI: 10.1002/smll.202206415] [Reference Citation Analysis]
|
2 |
Identification of Lysosome-related Biomarkers for Predicting Prognosis and Immunotherapeutic Response in Breast Cancer.. [DOI: 10.21203/rs.3.rs-2405680/v2] [Reference Citation Analysis]
|
3 |
Zhang J, Wang X, Duan M, Zhang Z, Jiang M, Li J, Liu X, Ren Y, Wang Y, Jia H. Identification of Lysosome-related Biomarkers for Predicting Prognosis and Immunotherapeutic Response in Breast Cancer.. [DOI: 10.21203/rs.3.rs-2405680/v1] [Reference Citation Analysis]
|
4 |
Wei Z, Jiang Y, Zhao G, Li C, Han S, Chen Y, Wang T, Cheng T, Wang J, Wang C. Irradiation accelerates SARS-CoV-2 infection by enhancing sphingolipid metabolism. J Med Virol 2023;95:e28266. [PMID: 36319186 DOI: 10.1002/jmv.28266] [Reference Citation Analysis]
|
5 |
Gao C, Chen Y, Cheng X, Zhang Y, Zhang Y, Wang Y, Cui Z, Liao Y, Luo P, Wu W, Wang C, Zeng H, Zou Q, Gu J. A novel structurally identified epitope delivered by macrophage membrane-coated PLGA nanoparticles elicits protection against Pseudomonas aeruginosa. J Nanobiotechnology 2022;20:532. [PMID: 36517801 DOI: 10.1186/s12951-022-01725-x] [Reference Citation Analysis]
|
6 |
Yan J, Fei W, Song Q, Zhu Y, Bu N, Wang L, Zhao M, Zheng X. Cell membrane-camouflaged PLGA biomimetic system for diverse biomedical application. Drug Deliv 2022;29:2296-319. [PMID: 35861175 DOI: 10.1080/10717544.2022.2100010] [Reference Citation Analysis]
|
7 |
Liu S, Li L, Zhang X, Meng Q. Nanotherapies from an oncologist doctor's view. Smart Materials in Medicine 2022. [DOI: 10.1016/j.smaim.2022.07.005] [Reference Citation Analysis]
|
8 |
Ren Q, Yi C, Pan J, Sun X, Huang X. Smart Fe3O4@ZnO Core-Shell Nanophotosensitizers Potential for Combined Chemo and Photodynamic Skin Cancer Therapy Controlled by UVA Radiation. IJN 2022;Volume 17:3385-400. [DOI: 10.2147/ijn.s372377] [Reference Citation Analysis]
|
9 |
Dai J, Chen Z, Wang S, Xia F, Lou X. Erythrocyte membrane-camouflaged nanoparticles as effective and biocompatible platform: Either autologous or allogeneic erythrocyte-derived. Materials Today Bio 2022. [DOI: 10.1016/j.mtbio.2022.100279] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
10 |
Delahunty I, Li J, Jiang W, Lee C, Yang X, Kumar A, Liu Z, Zhang W, Xie J. 7-Dehydrocholesterol Encapsulated Polymeric Nanoparticles As a Radiation-Responsive Sensitizer for Enhancing Radiation Therapy. Small 2022;:e2200710. [PMID: 35304816 DOI: 10.1002/smll.202200710] [Reference Citation Analysis]
|
11 |
Han H, Bártolo R, Li J, Shahbazi M, Santos HA. Biomimetic platelet membrane-coated nanoparticles for targeted therapy. European Journal of Pharmaceutics and Biopharmaceutics 2022;172:1-15. [DOI: 10.1016/j.ejpb.2022.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
|
12 |
Shen X, Liu X, Li T, Chen Y, Chen Y, Wang P, Zheng L, Yang H, Wu C, Deng S, Liu Y. Recent Advancements in Serum Albumin-Based Nanovehicles Toward Potential Cancer Diagnosis and Therapy. Front Chem 2021;9:746646. [PMID: 34869202 DOI: 10.3389/fchem.2021.746646] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
13 |
Yi X, Shen M, Liu X, Gu J. Emerging strategies based on nanomaterials for ionizing radiation-optimized drug treatment of cancer. Nanoscale 2021;13:13943-61. [PMID: 34477676 DOI: 10.1039/d1nr03034e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
14 |
Peng Z, Yuan L, XuHong J, Tian H, Zhang Y, Deng J, Qi X. Chiral nanomaterials for tumor therapy: autophagy, apoptosis, and photothermal ablation. J Nanobiotechnology 2021;19:220. [PMID: 34294083 DOI: 10.1186/s12951-021-00965-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
|
15 |
Clement S, Anwer AG, Pires L, Campbell J, Wilson BC, Goldys EM. Radiodynamic Therapy Using TAT Peptide-Targeted Verteporfin-Encapsulated PLGA Nanoparticles. Int J Mol Sci 2021;22:6425. [PMID: 34204001 DOI: 10.3390/ijms22126425] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
16 |
Hussain Z, Rahim MA, Jan N, Shah H, Rawas-Qalaji M, Khan S, Sohail M, Thu HE, Ramli NA, Sarfraz RM, Abourehab MAS. Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy. J Control Release 2021;335:130-57. [PMID: 34015400 DOI: 10.1016/j.jconrel.2021.05.018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
|
17 |
Wang C, Wang S, Chen Y, Zhao J, Han S, Zhao G, Kang J, Liu Y, Wang L, Wang X, Xu Y, Wang S, Huang Y, Wang J, Zhao J. Membrane Nanoparticles Derived from ACE2-Rich Cells Block SARS-CoV-2 Infection. ACS Nano 2021;15:6340-51. [PMID: 33734675 DOI: 10.1021/acsnano.0c06836] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 15.0] [Reference Citation Analysis]
|
18 |
Gong C, Yu X, Zhang W, Han L, Wang R, Wang Y, Gao S, Yuan Y. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles. J Nanobiotechnology 2021;19:58. [PMID: 33632231 DOI: 10.1186/s12951-021-00805-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
|
19 |
Kunde SS, Wairkar S. Platelet membrane camouflaged nanoparticles: Biomimetic architecture for targeted therapy. Int J Pharm 2021;598:120395. [PMID: 33639226 DOI: 10.1016/j.ijpharm.2021.120395] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
|
20 |
Adityan S, Tran M, Bhavsar C, Wu SY. Nano-therapeutics for modulating the tumour microenvironment: Design, development, and clinical translation. Journal of Controlled Release 2020;327:512-32. [DOI: 10.1016/j.jconrel.2020.08.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
|
21 |
Wang C, Wang S, Chen Y, Zhao J, Han S, Zhao G, Kang J, Liu Y, Wang L, Wang X, Xu Y, Wang S, Huang Y, Wang J, Zhao J. Membrane Nanoparticles Derived from ACE2-rich Cells Block SARS-CoV-2 Infection.. [DOI: 10.1101/2020.08.12.247338] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|